Intravenous lidocaine for neuropathic pain: Diagnostic utility and therapeutic efficacy

被引：20

作者：

Carroll I. ^{[1
]}

机构：

[1] Stanford University School of Medicine, Palo Alto, CA 94034

来源：

Current Pain and Headache Reports | 2007年 / 11卷 / 1期

关键词：

Lidocaine; Neuropathic Pain; Complex Regional Pain Syndrome; Mexiletine; Mechanical Allodynia;

D O I：

10.1007/s11916-007-0017-7

中图分类号：

学科分类号：

摘要：

Lidocaine is a use-dependent sodium channel blocker that produces analgesia when administered intravenously to patients with neuropathic pain. This article reviews the role and limitations of intravenous lidocaine infusions for neuropathic pain. Lidocaine infusions rarely provide relief that persists significantly beyond the duration of the infusion. Diagnostically, systemic lidocaine may help establish the presence of neuropathic pain and the responsivity to oral sodium channel blockade. However, the data supporting diagnostic infusions remain sparse. Therapeutically, infusions should generally be restricted to patients with neuropathic pain who are unable to take oral medication. Copyright © 2007 by Current Medicine Group LLC.

引用

页码：20 / 24

页数：4

共 28 条

[1]

Devor M., Wall P.D., Catalan N., Systemic lidocaine silences ectopic neuroma and DRG discharge without blocking nerve conduction, Pain, 48, pp. 261-268, (1992)

[2]

Woolf C.J., Wiesenfeld-Hallin Z., The systemic administration of local anaesthetics produces a selective depression of C-afferent fibre evoked activity in the spinal cord, Pain, 23, pp. 361-374, (1985)

[3]

Sotgiu M.L., Biella G., Castagna A., Et al., Different time-courses of i.v. lidocaine effect on ganglionic and spinal units in neuropathic rats, Neuroreport, 5, pp. 873-876, (1994)

[4]

Attal N., Gaude V., Brasseur L., Et al., Intravenous lidocaine in central pain: A double-blind, placebo-controlled, psychophysical study, Neurology, 54, pp. 564-574, (2000)

[5]

Leong M.S., Solvason H.B., Case report: Limbic system activation by intravenous lidocaine in a patient with a complex regional pain syndrome and major depression, Pain Med, 1, pp. 358-361, (2000)

[6]

Benson B.E., Carson R.E., Kiesewetter D.O., Et al., A potential cholinergic mechanism of procaine's limbic activation, Neuropsychopharmacology, 29, pp. 1239-1250, (2004)

[7]

Parekh P.I., Spencer J.W., George M.S., Et al., Procaine-induced increases in limbic rCBF correlate positively with increases in occipital and temporal EEG fast activity, Brain Topogr, 7, pp. 209-216, (1995)

[8]

Servan-Schreiber D., Perlstein W.M., Cohen J.D., Mintun M., Selective pharmacological activation of limbic structures in human volunteers: A positron emission tomography study, J Neuropsychiatry Clin Neurosci, 10, pp. 148-159, (1998)

[9]

Mao J., Chen L.L., Systemic lidocaine for neuropathic pain relief, Pain, 87, pp. 7-17, (2000)

[10]

Tremont-Lukats I.W., Challapalli V., McNicol E.D., Et al., Systemic administration of local anesthetics to relieve neuropathic pain: A systematic review and meta-analysis, Anesth Analg, 101, pp. 1738-1749, (2005)

← 1 2 3 →